A member of the acyl-CoA synthetase (ACS) family, acyl CoA synthetase 4 (ACSL4) has been identified as an oncogene and a novel marker of alpha-fetoprotein-high subtype HCC. Here, ACSL4 is linked to hepatocellular carcinoma.